STAXYN

Administration of STAXYN with nitrates and nitric oxide donors is contraindicated. Consistent with the effects of PDE5 inhibition on the nitric

...continue reading

SEP3 Success Rate (%)"scrollbars=yes, resizable=yes, width=400, height=400,top=500, left=500"[1]

Based on a randomized, double-blind, placebo-controlled, 12-week trial of STAXYN in men (N=355) with ED. Randomization was stratified so that approximately 50% of patients were ≥65 years old. All 3 coprimary endpoints, SEP2, SEP3, and IIEF-EF domain scores, achieved statistically and clinically significant improvements with STAXYN vs placebo. The primary endpoints were assessed at 3 months."scrollbars=yes, resizable=yes, width=400, height=400,top=500, left=500"[1]

In another similar study, STAXYN significantly improved erectile function"scrollbars=yes, resizable=yes, width=400, height=400,top=500, left=500"[1,3]

Based on a randomized, double-blind, placebo-controlled, 12-week trial of STAXYN in men (N=331) with ED. All 3 coprimary endpoints, SEP2, SEP3, and IIEF-EF domain scores, achieved statistically and clinically significant improvements with STAXYN vs placebo at 3 months."scrollbars=yes, resizable=yes, width=400, height=400,top=500, left=500"[3]

* Sexual Encounter Profile Question 2 (SEP2): "Were you able to insert your penis into your partner's vagina?"
International Index of Erectile Function – Erectile Function Domain (IIEF–EF).
Sexual Encounter Profile Question 3 (SEP3): "Did your erection last long enough for you to have successful intercourse?"